COPD Patients Have Short Lung Magnetic Resonance T₁ Relaxation Time

References

• Stockley RA, Mannino D, Barnes PJ. Burden and pathogenesis of chronic obstructive pulmonary disease. Proc Amer Thorac Soc 2009; 6(6):524–526.
   PubMedGoogle Scholar
• Bergin C, Müller N, Nichols D, et al. The diagnosis of emphysema. A computed tomographic-pathologic correlation. Am Rev Respir Dis 1986; 133(4):541.
   PubMed Web of Science ®Google Scholar
• Swanney MP, Ruppel G, Enright PL, et al. Using the lower limit of normal for the FEV1/FVC ratio reduces the misclassification of airway obstruction. Thorax 2008; 63(12):1046–1051.
   PubMed Web of Science ®Google Scholar
• Roy K, Smith J, Kolsum U, et al. COPD phenotype description using principal components analysis. Respir Res 2009; 10(1):41.
   PubMed Web of Science ®Google Scholar
• Costa GM, Faria ACD, Mango D, et al. Bronchodilation in COPD: Beyond FEV1-the effect of albuterol on resistive and reactive properties of the respiratory system. J Brasil Pneumol 2009; 35(4):325–333.
   PubMed Web of Science ®Google Scholar
• Jones P, Agusti A. Outcomes and markers in the assessment of chronic obstructive pulmonary disease. Euro Respir J 2006; 27(4):822–832.
   PubMed Web of Science ®Google Scholar
• Agusti A. The path to personalised medicine in COPD. Thorax 2014; 69(9):857–864.
   PubMed Web of Science ®Google Scholar
• Lynch DA. Imaging of small airways disease and chronic obstructive pulmonary disease. Clin Chest Med. 2008; 29(1):165–179.
   PubMed Web of Science ®Google Scholar
• Jögi J, Ekberg M, Jonson B, et al. Ventilation/perfusion SPECT in chronic obstructive pulmonary disease: An evaluation by reference to symptoms, spirometric lung function and emphysema, as assessed with HRCT. Euro J Nucl Med Mol Imag. 2011; 38(7):1344–1352.
   PubMed Web of Science ®Google Scholar
• Wild J, Marshall H, Bock M, et al. MRI of the lung (1/3): Methods. Insights Imag 2012; 3(4):345–353.
   PubMedGoogle Scholar
• Biederer J, Beer M, Hirsch W, et al. MRI of the lung (2/3). why… when… how? Insights Imag 2012; 3:1–17.
   Google Scholar
• Biederer J, Mirsadraee S, Beer M, et al. MRI of the lung (3/3)—current applications and future perspectives. Insights Imag 2012; 3:1–14.
   Google Scholar
• Edelman RR, Hatabu H, Tadamura E, et al. Noninvasive assessment of regional ventilation in the human lung using oxygen–enhanced magnetic resonance imaging. Nat Med 1996; 2(11):1236–1239.
   PubMed Web of Science ®Google Scholar
• Ohno Y, Hatabu H. Basics concepts and clinical applications of oxygen-enhanced MR imaging. Eur J Radiol 2007; 64(3):320–328.
   PubMed Web of Science ®Google Scholar
• Ohno Y, Iwasawa T, Seo JB, et al. Oxygen-enhanced magnetic resonance imaging versus computed tomography: Multicenter study for clinical stage classification of smoking-related chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2008; 177(10):1095–1102.
   PubMed Web of Science ®Google Scholar
• Morgan AR, Parker GJ, Roberts C, et al. Feasibility assessment of using oxygen-enhanced magnetic resonance imaging for evaluating the effect of pharmacological treatment in COPD. Eur J Radiol 2014; 83(11):2093–2101.
   PubMed Web of Science ®Google Scholar
• Triphan SM, Breuer FA, Gensler D, et al. Oxygen enhanced lung MRI by simultaneous measurement of T1 and T2* during free breathing using ultrashort TE. J Magnet Reson Imag 2014; 41:1708–1714.
   Web of Science ®Google Scholar
• Scholz TD, Fleagle SR, Burns TL, et al. Tissue determinants of nuclear magnetic resonance relaxation times. effect of water and collagen content in muscle and tendon. Invest Radiol 1989; 24(11):893–898.
   Google Scholar
• Deninger A, Eberle B, Ebert M, et al. Quantification of regional intrapulmonary oxygen partial pressure evolution during apnea by 3He MRI. J Magn Reson 1999; 141(2):207–216.
   PubMed Web of Science ®Google Scholar
• Stadler A, Jakob PM, Griswold M, et al. T1 mapping of the entire lung parenchyma: Influence of respiratory phase and correlation to lung function test results in patients with diffuse lung disease. Magn Reson Med 2007; 59(1):96–101.
   Web of Science ®Google Scholar
• Dasenbrook EC, Lu L, Donnola S, et al. Normalized T1 magnetic resonance imaging for assessment of regional lung function in adult cystic fibrosis patients-A cross-sectional study. PloS One 2013; 8(9):e73286.
   PubMed Web of Science ®Google Scholar
• Rabe KF, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine. 2007 September15; 176(6):532–55.
   PubMed Web of Science ®Google Scholar
• Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J 2005; 26(2):319–338.
   PubMed Web of Science ®Google Scholar
• Kingsley PB, Gordon Monahan W. Effect of increased repetition time TR on precision of inversion-recovery T1 measurements. Magn Reson Imag 2001; 19(2):279–282.
   PubMed Web of Science ®Google Scholar
• Bottomley P, Hardy C, Argersinger R, et al. A review of 1H nuclear magnetic resonance relaxation in pathology: Are T1 and T2 diagnostic? Med Phys 1987; 14(1):1–37.
   PubMed Web of Science ®Google Scholar
• Harms SE, editor. Breast MRI: Fundamentals and Technical Aspects, In. Hendrick RE, ed. Tissue Relaxation. New York, NY: Springer; 2008:19–29.
   Google Scholar
• Zhang X, Petersen E, Ghariq E, et al. In vivo blood T1 measurements at 1.5 T, 3 T, and 7 T. Magn Reson Med 2013; 70(4):1082–1086.
   PubMed Web of Science ®Google Scholar
• Vinitski S, Pearson MG, Karlik SJ, et al. Differentiation of parenchymal lung disorders with in vitro proton nuclear magnetic resonance. Magn Reson Med. 1986 Feb; 3(1):120–125.
   PubMed Web of Science ®Google Scholar
• Stadler A, Jakob PM, Griswold M, et al. T1 mapping of the entire lung parenchyma: Influence of the respiratory phase in healthy individuals. J Magn Reson Imag 2005; 21(6):759–764.
   PubMed Web of Science ®Google Scholar
• Zhang W, Hubbard Cristinacce PL, Bondesson E, et al. MR quantitative equilibrium signal mapping: A reliable alternative to CT in the assessment of emphysema in patients with chronic obstructive pulmonary disease. Radiology 2015; 275:579–588.
   Web of Science ®Google Scholar
• Waterton J. Translational magnetic resonance imaging and spectroscopy: opportunities and challenges In: Garrido L, Beckmann N, editors. New Applications of NMR in Drug Discovery and Development. Cambridge, UK: Royal Society of Chemistry; 2013: 333–360.
   Google Scholar
• Parr DG, Dirksen A, Piitulainen E, et al. Exploring the optimum approach to the use of CT densitometry in a randomised placebo-controlled study of augmentation therapy in alpha 1-antitrypsin deficiency. Respir Res 2009; 10(75):75.
   PubMed Web of Science ®Google Scholar
• Shaker SB, Maltbaek N, Brand P, et al. Quantitative computed tomography and aerosol morphometry in COPD and alpha1-antitrypsin deficiency. Eur Respir J 2005; 25(1):23–30.
   PubMed Web of Science ®Google Scholar